APA Corporation Form 8-K Summary
Business context and reporting period
APA Corporation filed a Form 8-K regarding its January 3, 2024 entry into an Agreement and Plan of Merger with Callon Petroleum Company and APA subsidiary Astro Comet Merger Sub Corp. The report was signed January 4, 2024. This is a transaction-related filing and does not provide a quarterly or annual financial update.
Transaction terms and key financial matters
- Callon will survive the merger as a wholly owned subsidiary of APA, subject to the transaction terms.
- Each outstanding Callon common share, other than excluded shares, will be exchanged for 1.0425 shares of APA common stock, with cash paid for fractional shares.
- APA entered into a commitment letter for a senior unsecured bridge facility of up to $2.0 billion.
- The filing does not provide current revenue, profit, operating cash flow, margins, debt balances, liquidity balances, or other standalone financial metrics for APA or Callon.
Material changes versus the prior comparable period
The filing does not present comparative-period financial results. The material development is APA’s proposed stock-for-stock acquisition of Callon and the related potential financing arrangement.
Conditions, risks, contingencies, and unusual items
- Closing requires approval by APA and Callon shareholders, expiration or termination of the Hart-Scott-Rodino waiting period, no prohibitive governmental order or law, effectiveness of an APA Form S-4 registration statement, and Nasdaq authorization for the APA shares to be issued.
- Closing is also subject to customary accuracy of representations and warranties, performance of covenants, and the absence of a material adverse effect.
- The stated termination date is October 3, 2024, with possible three-month extensions for antitrust-related delays and a further extension by mutual agreement under specified conditions.
- Callon may owe APA an $85 million termination fee in specified circumstances. APA may owe Callon a $170 million termination fee in specified circumstances.
- If either shareholder vote fails under specified circumstances, the party whose shareholders failed to approve the transaction may owe expense reimbursement of up to $48 million for APA or $24 million for Callon. No party may receive more than one termination fee, net of expense reimbursement.
- Both companies are subject to customary restrictions on soliciting or pursuing competing acquisition proposals, subject to exceptions.
- APA must appoint a Callon-selected director to APA’s board immediately following the merger, subject to the agreement’s conditions.
- The transaction remains subject to regulatory, shareholder, financing, execution, integration, and market risks. The filing states that the merger agreement’s representations and warranties are contractual allocations of risk and should not be treated as factual descriptions for investors.
Most important facts for investors to verify
- Whether APA and Callon shareholder approvals are obtained.
- Whether the Form S-4 and joint proxy statement/prospectus are filed and become effective.
- Whether antitrust review is completed without conditions that materially alter the transaction.
- The final number of APA shares to be issued and the resulting dilution to existing APA shareholders.
- The definitive terms, availability, and ultimate use of the proposed $2.0 billion bridge facility, including any refinancing or replacement debt.
- Whether the merger closes by the applicable termination date and whether any termination fee or expense reimbursement becomes payable.
- Callon’s and APA’s standalone financial condition, debt, liquidity, production, reserves, and integration assumptions, which are not quantified in this filing.